Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy

Gynecologic Oncology

Volumn 121, Issue 2, 2011, Pages 323-327

  Cheng, X ^a,b   Yang, G ^a,b   Schmeler, K M ^a   Coleman, R L ^a   Tu, X ^b   Liu, J ^a   Kavanagh, J J ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b FUDAN UNIVERSITY   (China)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Endometrial stromal sarcoma; Hormonal therapy; Recurrence; Targeted therapy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; IMATINIB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROGESTERONE RECEPTOR; STEM CELL FACTOR; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; ENDOMETRIUM SARCOMA; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; SALPINGOOOPHORECTOMY;

ADULT; AGED; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MOLECULAR TARGETED THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, HORMONE-DEPENDENT; PARAFFIN EMBEDDING; PROGNOSIS; PROTEIN KINASE INHIBITORS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SARCOMA, ENDOMETRIAL STROMAL; YOUNG ADULT;

EID: 79955481960     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.12.360     Document Type: Article

References (32)

1. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M. Thun Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66 (Pubitemid 46148091)
2. L. Katz, M.J. Merino, H. Sakamoto, and P. Schwartz Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors Gynecol Oncol 26 1987 87 97 (Pubitemid 17213019)
3. G. Sutton, J. Kavanagh, and A. Wolfson Corpus: mesenchymal tumors W.J. Hoskins, C.A. Perez, R.C. Young, 4th ed Principles and practice of gynecologic oncology 2005 Lippincott Williams & Wilkins Philadelphia, PA 873 894
4. J.P. Shah, C.S. Bryant, and S. Kumar Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma Obstet Gynecol 112 2008 1102 1108
5. J.K. Chan, N.M. Kawar, and J.Y. Shin Endometrial stromal sarcoma: a population-based analysis Br J Cancer 99 2008 1210 1215
6. D. Pink, T. Lindner, and A. Mrozek Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature Gynecol Oncol 101 2006 464 469 (Pubitemid 44251067)
7. M.C. Chu, G. Mor, and C. Lim Low-grade endometrial stromal sarcoma: hormonal aspects Gynecol Oncol 2003 170 176 (Pubitemid 37338093)
8. W. Remmele, and K.H. Schicketanz Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer: computer-assisted image analysis (QIC score) vs. subjective grading (IRS) Pathol Res Pract 189 1993 862 866 (Pubitemid 23308006)
9. L.M. Ramondetta, D.C. Bodurka, and M.T. Deavers Uterine sarcomas P.J. Eifel, D.M. Gershenson, J.J. Kavanagh, M.D. Anderson Cancer Care series: gynecologic cancer 2006 Springer Science+Bussiness Media New York, NY 137 141
10. S. Kanjeekal, A. Chambers, and M.F.K. Fung Systemic therapy for advanced uterine sarcoma: a systematic review of the literature Gynecol Oncol 97 2005 624 637 (Pubitemid 40614914)
11. G. Sutton, J.A. Blessing, and R. Park Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group Obstet Gynecol 87 1996 747 750 (Pubitemid 26127095)
12. O. Reich, S. Regauer, and W. Urdl Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas Br J Cancer 82 5 2000 1030 1034 (Pubitemid 30128855)
13. R.L. Balleine, P.J. Earls, and L.R. Webster Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma Int J Gynecol Patho 23 2004 138 144 (Pubitemid 38391773)
14. O. Reich, and S. Regauer Hormonal therapy of endometrial stromal sarcoma Curr Opin Oncol 19 2007 347 352 (Pubitemid 46883524)
15. O. Reich, F.F. Nogales, and S. Regauer Gonadptropin-releasing hormone receptor expression in endometrial stromal sarcomas: an immunohistochemical study Modern Patho 18 2005 573 576 (Pubitemid 40478122)
16. L.M. Ramondetta, A.J. Johnson, and C.C. Sun Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma Cancer 115 2009 1867 1874
17. M. von Mehren New therapeutics for soft-tissue sarcomas in adults Oncology 21 2007 123
18. J.L. Yang, and P.J. Crowe Targeted therapies in adult soft tissue sarcomas J Surg Oncol 95 2007 183 184
19. R.E. Schmandt, R. Broaddus, and K. Lu Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-b in ovarian serous carcinoma and normal ovarian surface epithelium Cancer 98 2003 758 764 (Pubitemid 36959272)
20. B.M. Slomovitz, R.R. Broaddus, and R. Schmandt Expression of imatinib mesylate-targeted kinases in endometrial carcinoma Gynecol Oncol 95 2004 32 36 (Pubitemid 39286274)
21. B.J. Druker, S. Tamura, and E. Buchdunger Effects of selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells Nat Med 2 1996 561 566
22. M.A. Geller, P. Argenta, and W. Bradley Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression Gynecol Oncol 95 2004 632 636 (Pubitemid 39592532)
23. S.F. Adams, J.A. Hickson, and J.Y. Hutto PDGFR-a as a potential therapeutic target in uterine sarcomas Gyncol Oncol 104 2007 524 528 (Pubitemid 46240237)
24. B. Liegl, O. Reich, and F.F. Nogales PDGF-alpha and PDGF-beta are expressed in endometrial stromal sarcoma: a potential therapeutic target for tyrosine kinase inhibitors? Histopathology 49 2006 545 546 (Pubitemid 44631631)
25. B. Liegl, C. Gully, and O. Reich Expression of platelet-derived growth factor receptor in low-grade endometrial stromal sarcomas in the absence of activating mutations Histopathology 50 2007 448 452 (Pubitemid 46328189)
26. K. Ejskjar, B.S. Sorensen, and S.S. Poulsen Expression of the epidermal growth factor system in endometrioid endometrial cancer Gynecol Oncol 104 2007 158 167 (Pubitemid 46054118)
27. B. Tanner, D. Hasenclever, and K. Stern ErbB-3 predicts survival in ovarian cancer J Clin Oncol 24 2006 4317 4323 (Pubitemid 46630790)
28. F. Amant, V. Vloeberghs, and H. Woestenborghs ERBB-2 gene overexpression and amplification in uterine sarcoma Gynecol Oncol 95 2004 583 587 (Pubitemid 39592525)
29. A. Onn, A.M. Correa, and M. Gilcrease Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer Clin Cancer Res 10 2004 136 143 (Pubitemid 38114172)
30. S. Stadlmann, U. Gueth, and U. Reiser Epithelial growth factor receptor status in primary and recurrent ovarian cancer Mod Pathol 19 2006 607 610
31. F. Monifar, M. Gogg-Kamerer, and A. Sommersacher Endometrial stromal sarcomas frequently express epidermal growth factor receptor (EGFR, HER-1) Am J Surg Pathol 29 2005 485 489
32. R.J. Schilder, M.W. Sill, and R.B. Lee Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study J Clin Oncol 26 2008 3418 3425